Trevi Therapeutics to Present at Upcoming August Conferences
/PRNewswire/ -- Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™ (oral...
United States Rosalia Scampoli Katie Mcmanus Toby Maher Thomas Sciascia University Of Southern California
Source: prnewswire.com